Reply

Arthritis and Rheumatism

Volumn 58, Issue 3, 2008, Pages 912-913

  Thurlings, R M ^a   Vos, K ^a   Wijbrandts, C A ^a   Van Schaardenburg, D ^b   Gerlag, D M ^a   Tak, P P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD22 ANTIGEN; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ANTIGEN EXPRESSION; B LYMPHOCYTE; CONTROLLED STUDY; DRUG MEGADOSE; HUMAN; HUMAN CELL; LETTER; LYMPHOCYTE DEPLETION; MAST CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 40549102752     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23392     Document Type: Letter

References (8)

1. Godfrey HP, Ilardi C, Engber W, Graziano FM. Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 1984;27:852-6.
2. Krauth MT, Majlesi Y, Florian S, Bohm A, Hauswirth AW, Ghannadan M, et al. Cell surface membrane antigen phenotype of human gastrointestinal mast cells. Int Arch Allergy Immunol 2005;138:111-20.
3. Thurlings RM, Vos K, Wijbrandts CA, Zwinderman A, Gerlag DM, Tak PP. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis 2007. E-pub ahead of print.
4. Kavanaugh A, Rosengren S, Lee SJ, Hammaker D, Firestein GS, Kalunian K, et al. Assessment of rituximab's immunomodulatory synovial effects (the ARISE trial). I: clinical and synovial biomarker results. Ann Rheum Dis 2007. E-Pub ahead of print.
5. Walsh C, Fearon U, Fitzgerald O, Veale DJ, Bresnihan B. Decreased CD20 expression in rheumatoid arthritis synovium following rituximab therapy [abstract]. Arthritis Rheum 2006;54 Suppl 12:F132.
6. Dass S, Burgoyne CH, Vital EM, Reece RK, Rawstron AC, Ponchel F. Reduction in synovial B cell levels after rituximab in RA predicts clinical response [abstract]. Ann Rheum Dis 2007;66 Suppl 11:90.
7. Polyak MJ, Tailor SH, Deans JP. Identification of a cytoplasmic region of CD20 required for its redistribution to a detergent-insoluble membrane compartment. J Immunol 1998;161:3242-8.
8. Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum 2004;50:3783-91.